Skip to main content
letter
. 2022 Jun 17;85(4):436–480. doi: 10.1016/j.jinf.2022.06.011

Table 1.

Cases describing relapse of COVID-19 symptoms during out of hospital Paxlovid treatment.

Case number Age (years) Sex Comorbidities Medications Symptom onset LFT +ve Paxlovid duration Symptoms improved LFT -ve Symptoms reoccurred LFT +ve Hospitalised
1 55 Male Rheumatoid arthritis, vasculitis Rituximab
Prednisolone
Day 1 Day 1 Day 2 to Day 6 Day 5 to Day 7 Day 6 Day 8 Day 8 No
2 44 Female Crohn's disease Ustekinumab Day 1 Day 1
Day 2
Day 3
Day 4 to Day 9 Day 5 to Day 11 Day 5 to Day 11 Day 14 Day 14 (x3)
Day 15
No
3 59 Female Vasculitis Rituximab
Mycofenolate
Prednisolone
Hydroxychloroquine
Day 1 Day 1 Day 2 to Day 7 Day 3 to Day 5 Day 6 Day 19 Day 19 Assessed but not admitted